Real-World Observational Study to Assess Drug Utilisation Patterns in the US Among Migraine Patients Treated with Lasmiditan (H8H-MC-B005) First published 16/03/2023 Last updated 22/11/2024 EU PAS number:EUPAS45442 Study Finalised